Neko Health
Neko Health raises $260M Series B at $1.8B valuation
Quick Facts
Neko Health: Series B Funding Round
Neko Health has successfully raised $260M in Series B funding, reaching a valuation of $1.8B.
Company Overview
Develops advanced scanning technology for preventive healthcare and early disease detection
Funding Details
The Series B round was led by Atomico, with participation from Lakestar.
Company Information
- Headquarters: Stockholm, Sweden
- Founded: 2021
- Employees: 150+
- Category: HealthTech
Investment
Neko Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Atomico: Verified investor in Series B
- Lakestar: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
